ArticleVeterinary world2022
Brucellosis in livestock: First study on seroepidemiology, risk factors, and preventive strategies to manage the disease in Famenin, Iran.
Article in Veterinary world, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Spatio-temporal analysis of human brucellosis in North Khorasan, Iran (2015-2023): A cross-sectional study.One health (Amsterdam, Netherlands) · 2026Article
- Socio-economic impact of bovine brucellosis and the need for effective control strategies.Veterinary research communications · 2026Review
- The economic burden of brucellosis in Western Iran.Tropical medicine and health · 2025Article
- Epidemiological analysis of human brucellosis in North Khorasan province, Iran (2018-2023): a six-year multicenter retrospective study.BMC infectious diseases · 2025Article
- Socio-epidemiological study of bovine brucellosis: Seasonal cattle migration in Myanmar.Journal of advanced veterinary and animal research · 2025Article
- Seroprevalence and risk factors of small ruminant brucellosis in Jabodetabek, Indonesia.Veterinary world · 2025Article
- Bovine Brucellosis: First Comprehensive Evaluation from Hamedan, an Endemic Area in Iran.Indian journal of microbiology · 2024Article
- Detection ofIranian journal of veterinary research · 2024Article
- Brucellosis and One Health: Inherited and Future Challenges.Microorganisms · 2023Review
- Molecular Investigation ofArchives of Razi Institute · 2023Article
- Shedding rate of Brucella spp. in the milk of seropositive and seronegative dairy cattle.Heliyon · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Brucellosis is an infectious disease in humans and livestock. The disease is endemic in many regions of Iran, for example, Hamedan Province. Knowledge of infection rate and associated risk factors is essential to control and prevent the disease. The study aimed to estimate the prevalence of brucellosis and associated risk factors in cattle, sheep, and goats in Famenin, Hamedan Province, West of Iran. Materials and Methods: Blood samples of 1758 animals (1470 sheep, 190 goats, and 98 cattle) were obtained in different rural regions of Famenin. The samples were evaluated to detect of Results: About 6.88% and 89.31% of animals had a history of abortion and vaccination against brucellosis, respectively. Most of the animals were female (92.49%) and in the range of 2-3 age old (39.8%). The antibodies to the Conclusion: This is a comprehensive evaluation of animal brucellosis parallel to humans' cohort study in the Famenin region for the first time. Although the rate of brucellosis in animals is low in the region, explaining the risk factors to farmers, mass vaccination, regular screening of animals, and culling the positive animals are very important for controlling and reducing the disease in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.